Healthcare provider profile · identity verified

Eugen Stefanescu, M.D.

Family Practice · LINCOLN, CA · NPI 1225150774

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	555	202
Levothyroxine Sodium	Levothyroxine Sodium	403	129
Lisinopril	Lisinopril	357	122
Amlodipine Besylate	Amlodipine Besylate	318	121
Losartan Potassium	Losartan Potassium	284	96
Hydrochlorothiazide	Hydrochlorothiazide	225	89
Simvastatin	Simvastatin	192	68
Tamsulosin Hcl	Tamsulosin Hcl	192	63
Gabapentin	Gabapentin	186	70
Metoprolol Tartrate	Metoprolol Tartrate	184	57
Venlafaxine Hcl	Venlafaxine Hcl	183	62
Atenolol	Atenolol	173	63
Trazodone Hcl	Trazodone Hcl	164	53
Metformin Hcl	Metformin Hcl	140	49
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	132	47
Fluticasone Propionate	Fluticasone Propionate	124	62
Pantoprazole Sodium	Pantoprazole Sodium	124	47
Famotidine	Famotidine	122	47
Montelukast Sodium	Montelukast Sodium	120	48
Albuterol Sulfate Hfa	Albuterol Sulfate	118	71
Alendronate Sodium	Alendronate Sodium	118	41
Duloxetine Hcl	Duloxetine Hcl	118	43
Metoprolol Succinate	Metoprolol Succinate	114	38
Hydralazine Hcl	Hydralazine Hcl	101	39
Rosuvastatin Calcium	Rosuvastatin Calcium	101	34
Glipizide	Glipizide	97	35
Alvesco	Ciclesonide	96	37
Furosemide	Furosemide	94	34
Omeprazole	Omeprazole	91	37
Allopurinol	Allopurinol	89	31
Prednisone	Prednisone	70	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	21
Metformin Hcl Er	Metformin Hcl	65	27
Potassium Chloride	Potassium Chloride	65	19
Ibuprofen	Ibuprofen	62	29
Lorazepam	Lorazepam	58	18
Spiriva Respimat	Tiotropium Bromide	58	24
Meloxicam	Meloxicam	57	19
Warfarin Sodium	Warfarin Sodium	57	16
Fluoxetine Hcl	Fluoxetine Hcl	55	16
Pregabalin	Pregabalin	49	suppressed
Clonidine	Clonidine	46	15
Triamcinolone Acetonide	Triamcinolone Acetonide	46	27
Citalopram Hbr	Citalopram Hydrobromide	42	15
Ozempic	Semaglutide	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	16
Lovastatin	Lovastatin	40	12
Wixela Inhub	Fluticasone Propion/Salmeterol	39	suppressed
Finasteride	Finasteride	38	14
Fluocinonide	Fluocinonide	38	20
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	16
Terazosin Hcl	Terazosin Hcl	36	14
Acyclovir	Acyclovir	35	15
Azithromycin	Azithromycin	34	31
Pradaxa	Dabigatran Etexilate Mesylate	34	16
Buspirone Hcl	Buspirone Hcl	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	15
Carvedilol	Carvedilol	30	11
Jardiance	Empagliflozin	29	14
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Eliquis	Apixaban	28	12
Mirtazapine	Mirtazapine	27	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	13
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Humulin N	Insulin Nph Human Isophane	24	11
Ondansetron Hcl	Ondansetron Hcl	24	11
Glimepiride	Glimepiride	23	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	18
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Nystatin	Nystatin	18	12
Donepezil Hcl	Donepezil Hcl	17	suppressed
Erythromycin-Benzoyl Peroxide	Erythromycin/Benzoyl Peroxide	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Temazepam	Temazepam	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error